Skip to main content
Premium Trial:

Request an Annual Quote

Evogene Raises $7M in Second Financing Round

NEW YORK, March 2 (GenomeWeb News) -  Evogene completed its second round of financing, raising $7 million from existing and new investors from Israel, Europe, and North America, the company said yesterday.


Evogene previously announced the initial $1.75 million of this round, which was in the form of a convertible bridge loan from existing investors.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.